{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001127666.2:c.4321C>T",
          "cDNA Change": {
            "transcript": "NM_001127666.2",
            "ref": "C",
            "alt": "T",
            "position": "4321"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C"
        },
        {
          "HGVS": "NM_001127666.2:c.4322G>A",
          "cDNA Change": {
            "transcript": "NM_001127666.2",
            "ref": "G",
            "alt": "A",
            "position": "4322"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "G",
            "position": "1441"
          },
          "Description in input context": "R1441G"
        },
        {
          "HGVS": "NM_001127666.2:c.4323A>C",
          "cDNA Change": {
            "transcript": "NM_001127666.2",
            "ref": "A",
            "alt": "C",
            "position": "4323"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "H",
            "position": "1441"
          },
          "Description in input context": "R1441H"
        },
        {
          "HGVS": "NM_001127666.2:c.5099T>C",
          "cDNA Change": {
            "transcript": "NM_001127666.2",
            "ref": "T",
            "alt": "C",
            "position": "5099"
          },
          "Protein Change": {
            "ref": "Y",
            "alt": "C",
            "position": "1699"
          },
          "Description in input context": "Y1699C"
        },
        {
          "HGVS": "NM_001127666.2:c.6212T>G",
          "cDNA Change": {
            "transcript": "NM_001127666.2",
            "ref": "T",
            "alt": "G",
            "position": "6212"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "G",
            "position": "2037"
          },
          "Description in input context": "I2020T"
        },
        {
          "HGVS": "NM_001127666.2:c.6173G>A",
          "cDNA Change": {
            "transcript": "NM_001127666.2",
            "ref": "G",
            "alt": "A",
            "position": "6173"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "H",
            "position": "2025"
          },
          "Description in input context": "R1728H"
        },
        {
          "HGVS": "NM_001127666.2:c.6177G>A",
          "cDNA Change": {
            "transcript": "NM_001127666.2",
            "ref": "G",
            "alt": "A",
            "position": "6177"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2026"
          },
          "Description in input context": "G2019S"
        },
        {
          "HGVS": "NM_001127666.2:c.6181A>G",
          "cDNA Change": {
            "transcript": "NM_001127666.2",
            "ref": "A",
            "alt": "G",
            "position": "6181"
          },
          "Protein Change": {
            "ref": "T",
            "alt": "V",
            "position": "2027"
          },
          "Description in input context": "T2031S"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005313"
  },
  "Experiment Method": [
    {
      "Assay Method": "Co-immunoprecipitation",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with LRRK2 variants and 14-3-3 antibodies were used for immunoprecipitation."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001127666.2:c.4321C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced 14-3-3 binding",
          "Result Description": "R1441C showed significantly reduced interaction with 14-3-3 compared to wild-type."
        },
        {
          "Variant": "NM_001127666.2:c.4322G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced 14-3-3 binding",
          "Result Description": "R1441G showed reduced 14-3-3 binding and increased inclusion body formation."
        },
        {
          "Variant": "NM_001127666.2:c.4323A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced 14-3-3 binding",
          "Result Description": "R1441H exhibited impaired 14-3-3 interaction and increased aggregation."
        },
        {
          "Variant": "NM_001127666.2:c.5099T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced 14-3-3 binding",
          "Result Description": "Y1699C showed decreased 14-3-3 binding and increased inclusion body formation."
        },
        {
          "Variant": "NM_001127666.2:c.6212T>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced 14-3-3 binding",
          "Result Description": "I2020T exhibited impaired 14-3-3 binding and increased aggregation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each immunoprecipitation was repeated in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control for 14-3-3 binding."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Description": "Known pathogenic variants (e.g., G2019S) were included as validation controls."
      },
      "Validation controls N/LN": {
        "Validation controls N/LN": "Yes",
        "Description": "Non-pathogenic variants (e.g., R1441C) were used for comparison."
      },
      "Approved assay": "Yes"
    },
    {
      "Assay Method": "Kinase activity assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "LRRK2 variants were expressed in HEK293 cells, and kinase activity was measured using phosphorylation assays."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001127666.2:c.6177G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased kinase activity",
          "Result Description": "G2019S exhibited a 2-3 fold increase in kinase activity compared to wild-type."
        },
        {
          "Variant": "NM_001127666.2:c.6181A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased kinase activity",
          "Result Description": "T2031S showed a moderate increase in kinase activity."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each kinase assay was repeated in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control for kinase activity."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Description": "Known pathogenic variants (e.g., G2019S) were included as validation controls."
      },
      "Validation controls N/LN": {
        "Validation controls N/LN": "Yes",
        "Description": "Non-pathogenic variants (e.g., R1441C) were used for comparison."
      },
      "Approved assay": "Yes"
    },
    {
      "Assay Method": "Immunofluorescence localization",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK29线细胞",
        "Description": "LRRK2 variants were expressed in HEK293 cells, and localization was analyzed using immunofluorescence microscopy."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001127666.2:c.4321C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased inclusion bodies",
          "Result Description": "R1441C showed cytoplasmic aggregates and reduced nuclear localization."
        },
        {
          "Variant": "NM_001127666.2:c.4322G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased inclusion bodies",
          "Result Description": "R1441G exhibited diffuse cytoplasmic staining and increased inclusion bodies."
        },
        {
          "Variant": "NM_001127666.2:c.4323A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased inclusion bodies",
          "Result Description": "R1441H showed cytoplasmic aggregates and reduced membrane localization."
        },
        {
          "Variant": "NM_001127666.2:c.5099T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased inclusion bodies",
          "Result Description": "Y1699C exhibited cytoplasmic aggregates and reduced mitochondrial localization."
        },
        {
          "Variant": "NM_001127666.2:c.6212T>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased inclusion bodies",
          "Result Description": "I2020T showed cytoplasmic aggregates and reduced Golgi localization."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each immunofluorescence experiment was repeated in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control for normal localization."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Description": "Known pathogenic variants (e.g., G2019S) were included as validation controls."
      },
      "Validation controls N/LN": {
        "Validation controls N/LN": "Yes",
        "Description": "Non-pathogenic variants (e.g., R1441C) were used for comparison."
      },
      "Approved assay": "Yes"
    }
  ]
}